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We determined that the human papillomavirus type 18 (HPV18) regulatory region contains one functional GRE sequence
that interacts with the glucocorticoid receptor. This sequence conferred a moderate hormonal activation to the HPV18 P105
promoter. Two modulators of glucocorticoid hormone activity, AP1 and hbrm, both involved in P105 transcription, were found
not to interfere with this hormonal activation. q 1996 Academic Press, Inc.
The human papillomavirus type 18 (HPV18) has been has been shown to contain responsive elements for nu-
merous cellular factors including AP1 (9), NF1/CTF, andfound to be associated with the etiology of cervical carci-
KRF/Oct (10). Additional binding sites for transcriptionnomas, along with few other viral types forming the so-
factors are present more proximal to the promoter initia-called ‘‘high risk’’ group. Members of this group have
tion site, including Sp1 (11, 12), YY1 (13), AP1, and anbeen shown to express two transforming proteins, E6
Oct related site (14). In addition this region also containswhich interacts with p53 and induces its degradation and
binding sites for the viral E2 transcriptional regulator asE7 which interacts with the product of the cellular Rb
well as the origin of viral DNA replication. The E2 bindingtumor suppressor gene (1 –3). Transcription of these two
site most proximal to the promoter TATA box has beenoncogenes is apparently tightly regulated by a complex
shown to mediate repression of the E6/E7 promoter activ-array of cellular and viral proteins. This regulation may
ity by E2 (12, 15), while the three E2 binding sites arebe modified by integration of the viral genome, an event
crucial for viral DNA replication (16, 17). It should befrequently occurring during carcinogenic progression.
noted that this region of approximately 200 nt is devoidThe pattern of integration has been shown to be con-
of any intrinsic transcriptional activity in the absence ofserved, keeping intact a genomic fragment containing
its transcriptional enhancer (14). Within this proximal re-the whole regulatory region and the E6 and E7 genes,
gion, we found by computer search two putative GREwith a specific interruption in the downstream E1 and/or
elements, one at position 7756 containing 7 of 12 con-E2 ORFs (4, 5). In the free or integrated genomic form,
served residues with regard to the consensus GRE se-transcription of the viral oncogenes is under the control
quence (CCAACA N3 TGTCTA) and a second one atof numerous cellular factors, among which, are steroid
position 7839 containing 9 of 12 conserved residueshormone receptors. Epidemiological studies have raised
(AGCACA N3 TATACT). The existence of two potentialthe possibility that the hormonal status of the infected
sites might be correlated with the bimodal glucocorticoidperson, such as pregnancy, may influence the develop-
activation of the LCR of HPV18 linked to the lacZ genement of HPV-associated lesions (6).
in transgenic mice (18). Analysis by mutagenesis of PCR-Sequences resembling glucocorticoid hormone recep-
amplified DNA containing the two putative GRE sitestor response elements (GREs) have been identified in
indicated that only the GRE element at position 7839 isthe regulatory regions of HPVs associated with genital
hormone responsive (data not shown). Contrary to nu-lesions (7). The HPV16 genome has been shown to con-
merous hormone-responsive promoters where syner-tain such an element in its transcriptional enhancer (8).
gistic activation between at least two hormone-respon-In the HPV18 genome, the cell-type-specific enhancer
sive elements occurs (19), the HPV18 P105 promoter thus
appears to respond only to a single GRE element. This
1 To whom correspondence and reprint requests should be ad- element, present at position 7839, has been previously
dressed. Fax: 33-1-45 68 87 90. mentioned (7, 11).
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FIG. 1. (A) Activation of GRE tk CAT by the glucocorticoid hormone receptor. tk-CAT expression plasmids (0.5 mg) were cotransfected with 50 ng
of either the mutant glucocorticoid receptor (GRm) (black bars) or the wild-type GR (gray bars) expression plasmids in C33 cells by the standard
calcium phosphate coprecipitation method (29). The constitutive GR and its mutated version were expressed under a CMV promoter, as previously
described (30). CAT assays were done 40 hr posttransfection, results given are the mean of at least three experiments that were standardized with
the use of a cotransfected B-galactosidase reporter plasmid in each plate, and error bars are the calculated standard deviations. (B) Binding of
purified GR to wild-type and mutated GRE sequences. Purified glucocorticoid hormone receptor obtained from bacterial extracts was used for
binding assays with end-labeled probes by Klenow filling. Probes contain either wild-type (GRE18), AGCACA N3 TATACT, or mutated, AGCAAA N3
TATACT, sequences from HPV18 or a consensus GRE sequence (GREc), AGAACA N3 TGTTCT. Binding assays were performed under standard
conditions, in the absence of nonspecific competitor DNA. Briefly, proteins were incubated with the labeled probes in the presence of 12 mM
HEPES (pH 7.9), 0.5 mM EDTA, 4 mM MgCl2 , 60 mM KCl, and 20 mM spermidine. Competitions were done on a GREc-labeled probe with excess
unlabeled oligonucleotides containing the HPV18 or consensus GRE sequences using increasing molar excess as indicated at the top of each
lane.
We further examined whether this GRE sequence N3 TATACT) or a consensus GRE sequence (AGAACA
N3 TGTTCT) and cloned either one or two copies of themcould cooperate to increase the hormonal response
when multimerized. We synthesized oligonucleotides in front of the minimal thimidine kinase (tk) promoter.
As shown in Fig. 1A, both sequences mediated efficientcontaining either this HPV18 GRE sequence (AGCACA
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glucocorticoid receptor (GR)-dependent activation of the
tk promoter. In addition, both sequences increased the
hormonal response when duplicated, although the
HPV18 sequence was less efficient than the consen-
sus GRE.
To further compare the activity of the HPV18 GRE with
the consensus sequence, both oligonucleotides were
used in gel shift assays with a purified GR protein pro-
duced in bacteria. Both sequences were bound by the
purified GR; however, the consensus sequence bound
with a higher efficiency, as shown in direct binding
assays in Fig. 1B (compare lanes b, GR binding to the
HPV18 GRE, with lanes d and g, GR binding to the con-
sensus GRE). In competition experiments, with excess
unlabeled oligonucleotides, both the GREc and the
GRE18 sequences competed for the binding of GR to the
consensus sequence (Fig. 1B, lanes c to i). In contrast,
a mutated oligonucleotide containing a base change in
one of the conserved nucleotides of the HPV18 GRE ele-
ment (AGCAAA N3 TATACT) was neither bound by the
purified GR (Fig. 1B, lane a) nor did it compete for GR
binding (data not shown).
We next examined whether the P105/CAT plasmid, con-
taining the entire regulatory region cloned upstream of
the CAT gene (20), could be activated by cotransfection
with a constitutively expressed wild-type or mutated GR
FIG. 2. Hormonal regulation of the HPV18 P105/CAT construct con-in C33 cells. As shown in Fig. 2A, we detected a weak taining either a wild-type or a mutated GRE. (A) C33 cells were cotrans-
but reproducible transcriptional activation. It should be fected with 2 mg of the HPV18 P105/CAT plasmids and 50 ng of either
noted that control experiments (not shown) with highly GR (gray bars) or mutated GR (white bars) expression plasmids by the
standard calcium phosphate cotransfection method (29). The wild-typeresponsive regulatory regions such as the MMTV pro-
plasmid P105-wt has been described (9), and P105-GREm contains amoter showed a very high hormonal activation (30- to
single-base-pair mutation in the GRE, as described in the text and in
50-fold) in similar conditions. It therefore indicated the the legend to Fig. 1. CAT assays were done 40 hr after transfection.
presence of high concentrations of endogenous GR upon The values given represent the mean of at least three independent
transfection of the expression plasmid. In order to con- transfection experiments. (B) HeLa cells were transfected either with
the wild-type P105 promoter in front of CAT (l) or with the one containingfirm that the site that we identified by in vitro binding
the single GRE mutation (s). Cells were treated for 24 hr with differentwas indeed responsible for this activation of transcription
molar concentrations of dexamethasone, as indicated. Cell extracts
in the context of the whole HPV18 long control region, and CAT assays were done 40 hr after transfection. Each point is the
we introduced the point mutation within the GRE se- average of three independent transfection experiments.
quence that was shown to abolish GR binding in vitro
(Fig. 1B, lane a). We found that this mutation decreased
the promoter basal level and when cotransfected with endogenous receptors. A transfected HPV18 P105 wild-
type/CAT plasmid was activated 2- to 3-fold in differentthe constitutive GR, its transcription was further re-
pressed (Fig. 2A). This result unambiguously indicated experiments by dexamethasone treatment, but not the
one containing a mutated GRE sequence (Fig. 2B). Inthat the activation observed with the wild-type sequence
was due to the presence of an intact GRE sequence. The contrast, we could not detect hormonal activation of the
P105 promoter in the mammary tumor cell line MCF7unusual effect of the point mutation raises the possibility
that another cellular factor might bind to this site and which expresses a high level of endogenous receptors,
but does not support basal P105 transcription (data notcooperate with the glucocorticoid receptor. However, gel
shift assays with nuclear extracts failed, until now, to shown).
Our experiments indicated that a single point mutationdetect such a protein (results not shown). When the lev-
els of both mutated and wild-type P105 transcription were in the GRE sequence is sufficient to abolish the glucocor-
ticoid responsiveness of the HPV18 P105 promoter. Incompared in the presence of cotransfected GR, the wild-
type sequence was 10-fold more active than the mutated addition, we have also shown that the single or multimer-
ized GRE sequence of HPV18 can efficiently confer glu-one (compare the two gray columns in Fig. 2A). Direct
activation of HPV18 transcription by glucocorticoids cocorticoid responsiveness to a minimal promoter. The
single point mutation that we have introduced in this GREcould also be observed in HeLa cells, which contain
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FIG. 3. Transcriptional activation by the glucocorticoid hormone receptor of HPV18 P105 promoters mutated in AP1 binding sites. The HPV18 P105/
CAT plasmids, either wt or mutated in either one or both AP1 binding sites (9), are schematically represented at the bottom of the figure (crossed
triangles indicate mutated AP1 binding sites). Two micrograms of each plasmid was cotransfected with 50 ng of GR (gray bars) or GR-mutated
(white bars) expression plasmids in C33 cells, as described in Fig. 2.
(A to C) led to a decrease in the basal activity of the P105 quence can repress the AP1 activity. The concomitant
promoter. This is in contrast with a double point mutation presence of TREs and GRE in a regulatory region can
(AA to GG) introduced in the same element by Butz and constitute ‘‘composite elements’’ as in the proliferin gene,
Hoppe-Seyler (1993) that led to increased basal activity for instance (23). Regulation of these composite elements
of this promoter (11). Opposite effects of different GRE led to either activation or repression. Our results indicate
mutants could be due to different sequence changes that that the TRE and GRE of HPV18 do not constitute com-
would affect other regulatory elements located in close posite elements since both sequences are located far
proximity, such as a YY1 element located just few bases from each other and seem to be regulated independently.
from the GRE. Another possibility is that endogenous Another explanation for the weak hormonal activation
hormonal receptors could interact with this sequence in of the HPV18 transcription could be that full activation
the absence of transfected GR and modulate the basal requires another cellular factor(s). The cellular hbrm pro-
P105 activity. tein, a constituent of a complex that modulates chromatin
The weak hormonal activation of P105 (two- to threefold)
could result from a putative negative interference of the
receptor with AP1, an essential element of the promoter
(9), since it is well documented that a complex cross-
talk exists between glucocorticoid hormone receptor and
the AP1 complex (21, 22). In several cases they antago-
nize each other while in others they cooperate in tran-
scriptional activation. Since the HPV18 regulatory region
contains two AP1-responsive sites and a GRE, we inves-
tigated whether these elements interfere or synergize
with each other. In agreement with previous results, sin-
gle or double AP1 mutations in the P105 promoter de-
creased its activity; however, all mutants were still acti-
vated roughly twofold by glucocorticoid receptor, as ob-
served for the wild-type promoter (Fig. 3). These
FIG. 4. Transcriptional activation by hbrm of the HPV18 P105/CATexperiments demonstrate that AP1-dependent activation
plasmid. Two micrograms of wt P105/CAT plasmid was cotransfectedof P105 did not imply any obvious negative or positive
with 50 ng of the GRm or GR expression plasmids in the presence ofinterference with the hormonal activation. In the converse
variable amounts (between 0 and 1 mg) of the hbrm expression plasmid
experiment, GR repressed transcription of a promoter in C33 cells. Transfections were done as indicated in the legend to Fig.
mutated in its GRE (Fig. 2A), still raising the possibility 2. Values plotted on the curves are the result of a typical transfection
experiment.that excess GR in the absence of its target DNA se-
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chardt for the gift of purified bacterial GR and for the gift of the CMVstructure, could represent such a candidate since it has
hbrm expression plasmid, R. Ovseiovich for participating in the genera-been shown to potentiate GR activation (24). We there-
tion of the GRE mutant, F. Arnos for technical help, and Christian De-
fore investigated the putative involvement of hbrm in the saintes for critical reading of the manuscript. This work was supported
GR-mediated activation of HPV18 transcription. Cotrans- in part by grants from CONACYT (1705M9209) and the Miguel Alema´n
fection of a cytomegalovirus promoter (CMV) hbrm ex- Foundation, the ARC, and the LNFCC.
pression plasmid with the P105 CAT plasmid in the C33
cell line (which does not express endogenous hbrm) pro-
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